Pliant Therapeutics (PLRX) Earnings Date, Estimates & Call Transcripts $1.40 -0.08 (-5.10%) As of 03:52 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pliant Therapeutics Earnings Summary Pliant Therapeutics announced Q4 2024 earnings on March 3, 2025, reporting an EPS of -$0.82, which topped analysts' consensus estimates of -$0.99 by $0.17. With a trailing EPS of -$3.47, Pliant Therapeutics' earnings are expected to decrease next year, from ($3.64) to ($3.72) per share. Upcoming Earnings DateMay. 19Before Market OpensEstimatedConsensus EPS (Mar. 3) -$0.99 Actual EPS (Mar. 3) -$0.82 Beat By $0.17 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)PLRX Upcoming EarningsPliant Therapeutics' Q1 2025 earnings is scheduled for Monday, May 19, 2025Powered by Get Pliant Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pliant Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPLRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PLRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Pliant Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.00-$0.86-$0.93Q2 20252-$0.55-$0.50-$0.53Q3 20252-$0.51-$0.51-$0.51Q4 20252-$0.65-$0.47-$0.56 Pliant Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/19/2025(Estimated)--------3/3/2025Q4 2024-$0.99-$0.82+$0.17-$0.82$0.08M-11/7/2024--$0.99-$0.95+$0.04-$0.95--8/7/2024--$0.85-$0.92 -$0.07-$0.92--5/6/2024Q1 2024-$0.76-$0.78 -$0.02-$0.78--2/27/2024Q4 2023--$0.69 -$0.69-$0.69--11/9/2023Q3 2023-$0.78-$0.70+$0.08-$0.70--8/9/2023Q2 2023-$0.73-$0.70+$0.03-$0.70$1.10M$0.25M Pliant Therapeutics Earnings - Frequently Asked Questions When is Pliant Therapeutics's earnings date? Pliant Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based off last year's report dates. Learn more on PLRX's earnings history. Did Pliant Therapeutics beat their earnings estimates last quarter? In the previous quarter, Pliant Therapeutics (NASDAQ:PLRX) reported ($0.82) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.99) by $0.17. Learn more on analysts' earnings estimate vs. PLRX's actual earnings. How much revenue does Pliant Therapeutics generate each year? Pliant Therapeutics (NASDAQ:PLRX) has a recorded annual revenue of $1.58 million. How much profit does Pliant Therapeutics generate each year? Pliant Therapeutics (NASDAQ:PLRX) has a recorded net income of -$161.34 million. PLRX has generated -$3.47 earnings per share over the last four quarters. What is Pliant Therapeutics's EPS forecast for next year? Pliant Therapeutics's earnings are expected to decrease from ($3.64) per share to ($3.72) per share in the next year. More Earnings Resources from MarketBeat Related Companies SIGA Technologies Earnings Date Kamada Earnings Date Revance Therapeutics Earnings Date Olema Pharmaceuticals Earnings Date COMPASS Pathways Earnings Date Oruka Therapeutics Earnings Date Aerovate Therapeutics Earnings Date SNDL Earnings Date Allogene Therapeutics Earnings Date Autolus Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:PLRX) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLRX Stock Free PLRX Stock Alerts